Home
DXCM
DXCM News

Latest DexCom Inc. (DXCM) News on May 9, 2025

DexCom, Inc. (DXCM): A Bull Case Theory

Insider Monkey

a day ago

DexCom, Inc. (DXCM): A Bull Case Theory

Argus Research

2 days ago

DXCM: Raising target price to $47.00

Argus Research

2 days ago

DXCM: Raising target price to $86.00

ŌURA rolls out glucose app linked with Dexcom’s CGM Stelo

Medical Device Network

3 days ago

ŌURA rolls out glucose app linked with Dexcom’s CGM Stelo

5 Best Stocks of the S&P 500 ETF in the Past Month

Zacks

4 days ago

5 Best Stocks of the S&P 500 ETF in the Past Month

MT Newswires

4 days ago

Barclays Adjusts DexCom Price Target to $93 From $90, Maintains Equal Weight Rating

DexCom (DXCM) Jumps 15% After Q1 Revenue Beat, $750M Buyback

GuruFocus.com

4 days ago

DexCom (DXCM) Jumps 15% After Q1 Revenue Beat, $750M Buyback

Why DexCom Inc. (DXCM) Soared Last Week

Insider Monkey

5 days ago

Why DexCom Inc. (DXCM) Soared Last Week

Why DexCom, Inc. (DXCM) Went Up On Friday

Insider Monkey

6 days ago

Why DexCom, Inc. (DXCM) Went Up On Friday

Morningstar Research

6 days ago

Analyst Report: DexCom, Inc.

S&P 500 Gains and Losses Today: Index Climbs as Strong Jobs Report Alleviates Economic Concerns

Investopedia

7 days ago

S&P 500 Gains and Losses Today: Index Climbs as Strong Jobs Report Alleviates Economic Concerns

MT Newswires

7 days ago

Sector Update: Health Care Stocks Climb Late Afternoon

DexCom Stock Rockets Higher To Lead S&P 500 Gainers

Investopedia

7 days ago

DexCom Stock Rockets Higher To Lead S&P 500 Gainers

MT Newswires

7 days ago

Top Midday Gainers

DexCom (NasdaqGS:DXCM) Announces US$750M Buyback and Reiterates 2025 Earnings Guidance

Simply Wall St.

7 days ago

DexCom (NasdaqGS:DXCM) Announces US$750M Buyback and Reiterates 2025 Earnings Guidance

DexCom Stock Rises Despite Q1 Earnings Miss & Lower Margins

Zacks

7 days ago

DexCom Stock Rises Despite Q1 Earnings Miss & Lower Margins

Thomson Reuters StreetEvents

7 days ago

Q1 2025 Dexcom Inc Earnings Call

MT Newswires

7 days ago

Redburn Atlantic Adjusts DexCom Price Target to $110 From $115

2 Growth Stocks to Buy and Hold for a Decade

Motley Fool

7 days ago

2 Growth Stocks to Buy and Hold for a Decade

DexCom Inc (DXCM) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Supply Challenges

GuruFocus.com

7 days ago

DexCom Inc (DXCM) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Supply Challenges

Compared to Estimates, DexCom (DXCM) Q1 Earnings: A Look at Key Metrics

Zacks

8 days ago

Compared to Estimates, DexCom (DXCM) Q1 Earnings: A Look at Key Metrics

DexCom (NASDAQ:DXCM) Exceeds Q1 Expectations

StockStory

8 days ago

DexCom (NASDAQ:DXCM) Exceeds Q1 Expectations

DexCom (DXCM) Q1 Earnings Miss Estimates

Zacks

8 days ago

DexCom (DXCM) Q1 Earnings Miss Estimates

MT Newswires

8 days ago

DexCom Q1 Non-GAAP Earnings Flat, Revenue Rises

MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK

Zacks

9 days ago

MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK

DexCom (DXCM) Q1 Earnings: What To Expect

StockStory

9 days ago

DexCom (DXCM) Q1 Earnings: What To Expect

Gear Up for DexCom (DXCM) Q1 Earnings: Wall Street Estimates for Key Metrics

Zacks

10 days ago

Gear Up for DexCom (DXCM) Q1 Earnings: Wall Street Estimates for Key Metrics

DXCM Q1 Earnings to Reflect U.S. Coverage Expansion & Stelo Impact?

Zacks

10 days ago

DXCM Q1 Earnings to Reflect U.S. Coverage Expansion & Stelo Impact?

Argus Research

16 days ago

DXCM: Lowering target price to $70.00

Argus Research

16 days ago

TRUP: Raising target price to $37.00

Dexcom Launches First Nationwide Search for College Athletes With Diabetes to Join Season Four of Dexcom U

Business Wire

17 days ago

Dexcom Launches First Nationwide Search for College Athletes With Diabetes to Join Season Four of Dexcom U

2 Cash-Producing Stocks That Stand Out and 1 to Keep Off Your Radar

StockStory

18 days ago

2 Cash-Producing Stocks That Stand Out and 1 to Keep Off Your Radar

3 Top Value Stocks Estimated To Be Up To 46.8% Below Intrinsic Value

Simply Wall St.

21 days ago

3 Top Value Stocks Estimated To Be Up To 46.8% Below Intrinsic Value

DexCom (NasdaqGS:DXCM) Gains FDA Clearance For Dexcom G7 System

Simply Wall St.

23 days ago

DexCom (NasdaqGS:DXCM) Gains FDA Clearance For Dexcom G7 System

Tariffs, Trump, and Turmoil

Motley Fool

23 days ago

Tariffs, Trump, and Turmoil

Argus Research

23 days ago

DXCM: Raising target price to $73.00

Argus Research

23 days ago

DXCM: Raising target price to $36.00

MT Newswires

24 days ago

RBC Cuts Price Target on DexCom to $100 From $115, Keeps Outperform Rating

DexCom Shares May Rise as G7 15-Day CGM System Gets FDA Clearance

Zacks

a month ago

DexCom Shares May Rise as G7 15-Day CGM System Gets FDA Clearance

Morningstar Research

a month ago

Analyst Report: DexCom, Inc.

Prada to acquire Versace, CarMax reports mixed Q4 results: Morning Buzz

TipRanks

a month ago

Prada to acquire Versace, CarMax reports mixed Q4 results: Morning Buzz

FDA Approves New DexCom Diabetes Device

Investopedia

a month ago

FDA Approves New DexCom Diabetes Device

FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch

Benzinga

a month ago

FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch

DexCom Stock Rises as Glucose Monitoring System Gets FDA Clearance

Barrons.com

a month ago

DexCom Stock Rises as Glucose Monitoring System Gets FDA Clearance

2 Growth Stocks to Buy in the Tariff-Fueled Market Correction

Motley Fool

a month ago

2 Growth Stocks to Buy in the Tariff-Fueled Market Correction

Dexcom nets FDA clearance for 15-day CGM

MedTech Dive

a month ago

Dexcom nets FDA clearance for 15-day CGM

Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device

Investor's Business Daily

a month ago

Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device

MT Newswires

a month ago

DexCom Says G7 15 Day Continuous Glucose Monitoring System Gets US FDA Clearance

Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System

Business Wire

a month ago

Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System

MT Newswires

a month ago

Mizuho Initiates DexCom at Outperform With $85 Price Target

Argus Research

a month ago

DXCM: Lowering target price to $64.00

Argus Research

a month ago

DXCM: Lowering target price to $35.00

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

StockStory

a month ago

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

DexCom (NasdaqGS:DXCM) Down 12% As Jon Coleman Becomes Chief Commercial Officer

Simply Wall St.

a month ago

DexCom (NasdaqGS:DXCM) Down 12% As Jon Coleman Becomes Chief Commercial Officer

MT Newswires

a month ago

Citigroup Adjusts DexCom Price Target to $80 From $104, Maintains Buy Rating

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now

Zacks

a month ago

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now

Morningstar Research

a month ago

Analyst Report: DexCom, Inc.

Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time.

Business Wire

a month ago

Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time.

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

StockStory

a month ago

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

Argus Research

a month ago

DXCM: Lowering target price to $39.00

Argus Research

a month ago

DXCM: Lowering target price to $71.00

DexCom (DXCM) Slid on Poor Execution and GLP-1 Drug Disruption Concerns

Insider Monkey

a month ago

DexCom (DXCM) Slid on Poor Execution and GLP-1 Drug Disruption Concerns

Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems

Business Wire

a month ago

Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems

DXCM Inks Deal With Nanowear to Boost CGM Application Beyond Diabetes

Zacks

a month ago

DXCM Inks Deal With Nanowear to Boost CGM Application Beyond Diabetes

Dexcom rejects claims of unauthorized device changes in FDA warning letter

MedTech Dive

a month ago

Dexcom rejects claims of unauthorized device changes in FDA warning letter

DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval

Zacks

a month ago

DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval

DexCom (NasdaqGS:DXCM) Expands Wearable Integration and Appoints New Chief Commercial Officer

Simply Wall St.

a month ago

DexCom (NasdaqGS:DXCM) Expands Wearable Integration and Appoints New Chief Commercial Officer

Dexcom’s FDA warning letter reveals unauthorized changes to sensors

MedTech Dive

a month ago

Dexcom’s FDA warning letter reveals unauthorized changes to sensors

DXCM Stock Gains Following New Data on Upcoming G7 CGM Sensor

Zacks

a month ago

DXCM Stock Gains Following New Data on Upcoming G7 CGM Sensor

Argus Research

a month ago

DXCM: Raising target price to $40.00

Argus Research

a month ago

DXCM: Raising target price to $77.00

MT Newswires

a month ago

DexCom Names Jon Coleman as Chief Commercial Officer

Dexcom Appoints Jon Coleman as Chief Commercial Officer

Business Wire

a month ago

Dexcom Appoints Jon Coleman as Chief Commercial Officer

Dexcom COO on 15-day glucose sensor, Type 2 coverage

MedTech Dive

a month ago

Dexcom COO on 15-day glucose sensor, Type 2 coverage

DexCom (DXCM): 3 Reasons We Love This Stock

StockStory

2 months ago

DexCom (DXCM): 3 Reasons We Love This Stock

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

StockStory

2 months ago

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

3 Stocks That May Be Trading Below Estimated Value In March 2025

Simply Wall St.

2 months ago

3 Stocks That May Be Trading Below Estimated Value In March 2025

Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next

Motley Fool

2 months ago

Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next

Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care

Business Wire

2 months ago

Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care

DexCom, Inc. (DXCM): Among the Best Diabetes Stocks to Buy According to Billionaires

Insider Monkey

2 months ago

DexCom, Inc. (DXCM): Among the Best Diabetes Stocks to Buy According to Billionaires

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 03/17/2025

DexCom CGM Sensor Sales to Continue Despite FDA Warning Letter

Zacks

2 months ago

DexCom CGM Sensor Sales to Continue Despite FDA Warning Letter

Analysts say Dexcom’s FDA warning unlikely to impact 2025 revenue

Medical Device Network

2 months ago

Analysts say Dexcom’s FDA warning unlikely to impact 2025 revenue

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

StockStory

2 months ago

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

Morningstar Research

2 months ago

Analyst Report: DexCom, Inc.

Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried

Investor's Business Daily

2 months ago

Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried

Top Stock Movers Now: Tesla, DexCom, Strategy, and More

Investopedia

2 months ago

Top Stock Movers Now: Tesla, DexCom, Strategy, and More

DexCom Stock Drops as Diabetes Devices Maker Gets FDA Warning Letter

Investopedia

2 months ago

DexCom Stock Drops as Diabetes Devices Maker Gets FDA Warning Letter

Dexcom Appoints Renée Galá to Board of Directors

Business Wire

2 months ago

Dexcom Appoints Renée Galá to Board of Directors

Dexcom receives warning letter based on FDA inspections of 2 plants

MedTech Dive

2 months ago

Dexcom receives warning letter based on FDA inspections of 2 plants

DexCom (NasdaqGS:DXCM) Shares Dip 1% Despite 7% Sales Growth

Simply Wall St.

2 months ago

DexCom (NasdaqGS:DXCM) Shares Dip 1% Despite 7% Sales Growth

Is DexCom, Inc. (DXCM) the Best Growth Stock Under $100 to Buy Now?

Insider Monkey

2 months ago

Is DexCom, Inc. (DXCM) the Best Growth Stock Under $100 to Buy Now?

Insiders Could Have Profited By Holding onto DexCom Shares Despite 12% Drop

Simply Wall St.

2 months ago

Insiders Could Have Profited By Holding onto DexCom Shares Despite 12% Drop

Dexcom receives FDA warning letter for two U.S. manufacturing facilities

Reuters

2 months ago

Dexcom receives FDA warning letter for two U.S. manufacturing facilities

DexCom Gets FDA Warning Letter After Inspections of Facilities

The Wall Street Journal

2 months ago

DexCom Gets FDA Warning Letter After Inspections of Facilities

MT Newswires

2 months ago

DexCom Receives US FDA Warning After Inspections

Argus Research

2 months ago

DXCM: Raising target price to $29.00

Argus Research

2 months ago

DXCM: Rating decreased to a SELL

Is DexCom, Inc.'s (NASDAQ:DXCM) ROE Of 27% Impressive?

Simply Wall St.

2 months ago

Is DexCom, Inc.'s (NASDAQ:DXCM) ROE Of 27% Impressive?

MT Newswires

2 months ago

Jefferies Adjusts Price Target on DexCom to $105 From $100, Keeps Buy Rating

Share on Social Networks: